BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 8769113)

  • 1. Regulation of fatty acid biosynthesis by intermediates of the cholesterol biosynthetic pathway.
    Ku EC
    Biochem Biophys Res Commun; 1996 Aug; 225(1):173-9. PubMed ID: 8769113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bifunctional inhibitors of mevalonate kinase and mevalonate 5-diphosphate decarboxylase.
    Qiu Y; Li D
    Org Lett; 2006 Mar; 8(6):1013-6. PubMed ID: 16524256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of the inhibition of cholesterol biosynthesis by 6-fluoromevalonate.
    Nave JF; d'Orchymont H; Ducep JB; Piriou F; Jung MJ
    Biochem J; 1985 Apr; 227(1):247-54. PubMed ID: 2986604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of the proliferation of Ras-transformed cells by fluoromevalonate, an inhibitor of mevalonate metabolism.
    Cuthbert JA; Lipsky PE
    Cancer Res; 1995 Apr; 55(8):1732-40. PubMed ID: 7712482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of fatty acid synthase-dependent neoplastic lipogenesis as the mechanism of gamma-linolenic acid-induced toxicity to tumor cells: an extension to Nwankwo's hypothesis.
    Menendez JA; Colomer R; Lupu R
    Med Hypotheses; 2005; 64(2):337-41. PubMed ID: 15607568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutation and inhibition studies of mevalonate 5-diphosphate decarboxylase.
    Qiu Y; Gao J; Guo F; Qiao Y; Li D
    Bioorg Med Chem Lett; 2007 Nov; 17(22):6164-8. PubMed ID: 17888661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of geraniol on fatty-acid and mevalonate metabolism in the human hepatoma cell line Hep G2.
    Polo MP; de Bravo MG
    Biochem Cell Biol; 2006 Feb; 84(1):102-11. PubMed ID: 16462894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lovastatin increases arachidonic acid levels and stimulates thromboxane synthesis in human liver and monocytic cell lines.
    Hrboticky N; Tang L; Zimmer B; Lux I; Weber PC
    J Clin Invest; 1994 Jan; 93(1):195-203. PubMed ID: 8282787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of cholesterol synthesis by squalene synthase inhibitors does not induce myotoxicity in vitro.
    Flint OP; Masters BA; Gregg RE; Durham SK
    Toxicol Appl Pharmacol; 1997 Jul; 145(1):91-8. PubMed ID: 9221828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of hepatic cholesterol biosynthesis by clofibrate administration.
    White LW
    J Pharmacol Exp Ther; 1971 Aug; 178(2):361-70. PubMed ID: 5570460
    [No Abstract]   [Full Text] [Related]  

  • 11. RPR 107393, a potent squalene synthase inhibitor and orally effective cholesterol-lowering agent: comparison with inhibitors of HMG-CoA reductase.
    Amin D; Rutledge RZ; Needle SN; Galczenski HF; Neuenschwander K; Scotese AC; Maguire MP; Bush RC; Hele DJ; Bilder GE; Perrone MH
    J Pharmacol Exp Ther; 1997 May; 281(2):746-52. PubMed ID: 9152381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of early cholesterol biosynthesis in rat liver: effects of sterols, bile acids, lovastatin, and BM 15.766 on 3-hydroxy-3-methylglutaryl coenzyme A synthase and acetoacetyl coenzyme A thiolase activities.
    Honda A; Salen G; Nguyen LB; Xu G; Tint GS; Batta AK; Shefer S
    Hepatology; 1998 Jan; 27(1):154-9. PubMed ID: 9425931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mevalonic acid analogs as inhibitors of cholesterol biosynthesis.
    DeBold CR; Elwood JC
    J Pharm Sci; 1981 Sep; 70(9):1007-10. PubMed ID: 6101142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of ethanol on cell growth and cholesterol metabolism in cultured Hep G2 cells.
    Polo MP; de Bravo MG; de Alaniz MJ
    Biochem Cell Biol; 2003 Dec; 81(6):379-86. PubMed ID: 14663504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of proliferation and Ras localization in transformed cells by products of mevalonate metabolism.
    Cuthbert JA; Lipsky PE
    Cancer Res; 1997 Aug; 57(16):3498-505. PubMed ID: 9270019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An alternative mechanism for the inhibition of cholesterol biosynthesis in HepG2 cells by N-[(1,5,9)-trimethyldecyl]-4 alpha,10-dimethyl-8-aza-trans-decal-3 beta-ol (MDL 28,815).
    Van Sickle WA; Wilson PK; Wannamaker MW; Cooper JR; Flanagan MA; McCarthy JR; Bey P; Jackson RL
    J Pharmacol Exp Ther; 1993 Dec; 267(3):1243-9. PubMed ID: 8263786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of cholesterol biosynthesis by fluorinated mevalonate analogues.
    Reardon JE; Abeles RH
    Biochemistry; 1987 Jul; 26(15):4717-22. PubMed ID: 3663621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
    Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
    Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lovastatin suppresses erythropoietin receptor surface expression through dual inhibition of glycosylation and geranylgeranylation.
    Hamadmad SN; Hohl RJ
    Biochem Pharmacol; 2007 Aug; 74(4):590-600. PubMed ID: 17586475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of cholesterol biosynthesis in primary cultured rat hepatocytes by artichoke (Cynara scolymus L.) extracts.
    Gebhardt R
    J Pharmacol Exp Ther; 1998 Sep; 286(3):1122-8. PubMed ID: 9732368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.